Health Technology Research AgendaNov 10, 2019
Monday, November 18, 10-11am
American Heart Association Scientific Sessions
Health Innovation Pavilion
Philadelphia Convention Center
There continues to be a paucity of high-quality research in the area of technology. As newer technologies are developed, such as artificial intelligence and machine learning, how do research designs adapt to this rapidly changing world?
This panel will be moderated by Dr. Eric Peterson from Duke University. Dr. Peterson will be joined by Dr. Michelle Longmire, CEO of Medable, Dr. Annabelle Volgman from Rush University, Dr. Cory Kidd, CEO of Catalia Health, and Dr. Gerard Cote from Texas A&M University.
Eric D. Peterson, MD, MPH, FAHA, FACC
Dr. Peterson is the Fred Cobb, MD Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and past executive director of the Duke Clinical Research Institute. Dr. Peterson is a recognized leader in outcomes and quality research, with over 1300 peer-reviewed publications. Dr. Peterson is the Principal Investigator of multiple studies including the NHLBI SPIRRIT Trial CC, ARTEMIS, INSPIRE-D, and CV MOBIUS. Dr. Peterson is chair of AHA’s Center of Health Technology and Innovation, and International Committee. He is a member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the Association of University Cardiologists (AUC). Dr. Peterson received the AHA Meritorious Achievement Award, Meritorious Research and QCOR Lifetime Achievement Awards. He is also a Contributing Editor at JAMA.
Michelle Longmire, MD
Michelle Longmire, M.D., founded Medable with the vision of making health technology as seamless and as integrated as the human body. With a background in image analysis and processing, she holds patents in machine learning as applied to medical diagnostics. Today, Dr. Longmire serves as the company’s CEO and leads the charge to enable a band of solutions in medical data and integration for more seamless and effective personalized health care delivery and clinical research management. The Medable platform removes the barriers to healthcare innovation to enable the development of life changing technologies efficiently, at scale, and with analytics capabilities that will transform the future of healthcare.”
Annabelle Volgman, MD
Annabelle Santos Volgman, MD, is a professor of medicine and has an endowed Chair for Excellence in Clinical Cardiology at Rush University. She is the founding medical director of the Rush Heart Center for Women. She received her medical degree from Columbia University College of Physicians and Surgeons in New York City. Her current research interests include sex differences in heart disease, preventive and management strategies of atrial fibrillation, and heart disease in women. She has written numerous papers, given hundreds of local, national and international lectures, and served as an editor/reviewer for several scientific journals.
Throughout her career, Volgman has been very active in efforts to increase awareness of heart disease in women, including being a prominent leader of the “Go Red for Women” movement. She serves on the national scientific advisory board of WomenHeart, current Chair of the American Heart Association Women in Cardiology committee, a member of the American Heart Association National International Committee. Highly respected by peers and patients alike, she has received numerous awards and honors from the American Heart Association — including the Coeur d’Or award at the 2011 and 2012 AHA’s Heart Ball. She was named by Today’s Chicago Woman magazine as one of the 100 Women Making a Difference in 2011; one of the 100 Most Influential Women in 2013; 100 Women of Inspiration; and one of 32 Chicago Women Role Models in 2014. She was among Castle Connolly’s top 1 percent of doctors in the nation in 2012 and 2013. She was the recipient of the 2019 Wenger Award for Innovation and will be a recipient of the 2020 Woman’s Day Red Dress Award in New York City. She was elected as the Illinois American College of Cardiology Governor-Elect in October 2019.
Cory Kidd, PhD
Dr. Cory Kidd is the founder and CEO of Catalia Health. Dr. Kidd has been working in healthcare technology for nearly two decades. The focus of his work has been applying innovative technologies towards solving large-scale healthcare challenges. His previous company, Intuitive Automata, created interactive coaches for weight loss. Prior to this, Dr. Kidd received his M.S. and Ph.D. at the MIT Media Lab in human-robot interaction. While there, he conducted studies that showed the psychological and clinical advantages of using a physical robot over screen-based interactions.
Gerry Cote’, PhD
Gerard L. Cote’ is the Texas A&M Regents Professor, Director of the Center for Remote Health Technologies and Systems, Director of the NSF PATHS-UP ERC, and holder of the James J. Cain Professor I in Biomedical Engineering at Texas A&M University. His research focuses on biomedical sensing for diagnostic and monitoring applications. Specifically, he develops innovative hand-held and wearable point-of-care technologies and systems using optics, electronics, microfluidics, paper fluidics, nanoparticles, and assays. The applications include glucose sensing methods for diabetes management, point-of-care detection of cardiac biomarkers, salivary biomarkers for diagnosing oral cancer detection, detection of infectious disease such as malaria at the point-of-care, and detection of toxicants such as BPA and PCBs in blood. His recent focus has been the development of wearable and hand-held medical devices for underserved populations. He has coauthored over 300 publications, proceedings, and abstracts, leading to him being named Fellow of four societies (IEEE, SPIE, BMES, and AIMBE). Dr. Coté has also been recognized Texas A&M Association of Former Students for the Distinguished Achievement Award for Research and Distinguished Achievement Award for Teaching. He was also awarded the 2018 IEEE Sensors Council Technical Achievement Award in the area of Sensors for pioneering research and a distinguished career of service to the profession. Beyond fundamental research, Dr. Coté performs translational research and is an entrepreneur. He holds several U.S. patents, works with large and small companies, and has co-founded three medical device companies namely; BioTex, BasePair BioTechnologies, and Visualase (acquired by Medtronic).